Linked Life Data

17611975

Source:http://linkedlifedata.com/resource/pubmed/id/17611975

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2007-7-5
pubmed:abstractText
Patients with rheumatoid arthritis (RA) who suffer an inadequate response to disease modifying antirheumatic drugs and biologic therapies represent a large segment of the RA population, so treating these patients is a major issue for physicians. The 4 case studies discussed in this article were presented at an American College of Rheumatology 2006 Annual Meeting Satellite Symposium and highlight some of the key issues for patients who are not responding adequately to current therapies. These issues include which therapy to consider next for maintaining tight control and maximizing outcomes in patients, and what is the rightful place of newly approved therapies within the current RA treatment armamentarium. Included here are the Audience Response System (ARS) results from the symposium, which will allow readers to compare their answers with that of the audience; this may help physicians in the decision-making process for their patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0380-0903
pubmed:author
pubmed:issnType
Print
pubmed:volume
79
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
21-6
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Disease modifiers: making the right therapeutic choices for our patients.
pubmed:affiliation
Department of Internal Medicine, University of Alabama, Birmingham, Alabama 35294, USA. larry.moreland@ccc.uab.edu
pubmed:publicationType
Journal Article, Case Reports